DeNovX Initiates Strategic R&D Collaboration with Scientists at SLAC National Accelerator Laboratory, Operated by Stanford University
DeNovX is pleased to announce that it has executed a [...]
DeNovX Expands its Strategic Partnerships to Include the Advanced Photon Source at Argonne National Laboratory, Operated by The University of Chicago
As part of a Phase II SBIR award from the [...]
DeNovX Establishes Strategic R&D Collaboration with Scientists at Massachusetts Institute of Technology (MIT)
In March of this year, DeNovX and MIT finalized details [...]
Patents on DeNovX’s Company-Owned Nucleation Surfaces Granted in Europe and Canada
DeNovX has received the exciting news that its company-owned patents [...]
DeNovX Scientists Busy Presenting Results at International Science Conferences
DeNovX scientists have been busy this year presenting their research [...]
DeNovX Scientists Complete their Fourth Data Collection Campaign at the Advanced Photon Source
DeNovX completed four data collection campaigns at the Advanced Photon [...]
Japan Patent Number 6414938 B2 Issues on DeNovX’s Platform for Improving Crystallization of Pharmaceuticals and Proteins
This Japanese patent is the follow on to issued US [...]
DeNovX Establishes Strategic Partnership and Collaborative Agreement with Scientists at Argonne National Laboratory
DeNovX is pleased to announce the establishment of a collaboration [...]
DeNovX’s Communication on its Company Owned Crystal Nucleation Technologies Publishes in Crystal Growth & Design
The initial publication describing DeNovX's patented approach to improving crystallization [...]
DeNovX to Study Pharmaceutical Co-Crystals Using Patented Crystallization Methods and Funding from the NIH
The National Institutes of Health have awarded DeNovX a Phase [...]